Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Multiple sklerose
by Highest Patent Value in the Germany in 2020

The Multiple sklerose top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Multiple sklerose Key Players in the Germany. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Multiple sclerosis is a progressive autoimmune disease that damages the insulating covers of brain cells. Depending on the brain region affected, it causes symptoms such as physical and mental dysfunction, fatigue, pain, depression, and anxiety [R+].
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 5.53 M
2
Health care,Medicine
Avg patent value: 5.52 M
3
Avg patent value: 4.85 M
4
Avg patent value: 4.48 M
5
Avg patent value: 4.39 M
6
Bayer Pharma AG
Avg patent value: 4.34 M
7
Biology,Health care,Fertility,
...[+2]
Avg patent value: 3.97 M
8
Autoimmune disease,Medicine,Health care,
...[+2]
Avg patent value: 3.49 M
9
Avg patent value: 2.50 M
10
B·R·A·H·M·S GmbH
Avg patent value: 1.86 M
11
Avg patent value: 1.15 M
12
Avg patent value: 1.01 M
13
Immunotherapy,Health care,Cell therapy,
...[+2]
Avg patent value: 890,000
14
Avg patent value: 670,000
15
Avg patent value: 425,400
16
Avg patent value: 380,000
17
Avg patent value: 65,000
18
Health care,Biology,Chemical engineering,
...[+2]
Avg patent value: 12,000
19
Pharmacy and Therapeutics,Lung cancer,Clinical trial,
...[+2]
Avg patent value: 0
20
Pharmacy and Therapeutics,Drug discovery,Small molecule,
...[+2]
Avg patent value: 0
Page generation time: Jul 23 2025